Clinical Trial Update: Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update of anastrozole +/- AZD8931 in postmenopausal women with endocrine therapy-naive breast cancer. The study was terminated and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• AZD8931 (AZD8931)

Snippet

Sponsor: AstraZeneca | Conditions: Neoplasms, Breast Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2014-05-08